|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 35/00 | |
| A61K 39/395 | |||
| C07K 16/28 | |||
| C07K 16/30 |
| (11) | Number of the document | 2739358 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12748808.8 |
| Date of filing the European patent application | 2012-08-01 | |
| (97) | Date of publication of the European application | 2014-06-11 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/049233 |
| Date | 2012-08-01 |
| (87) | Number | WO 2013/019906 |
| Date | 2013-02-07 |
| (30) | Number | Date | Country code |
| 201161574406 P | 2011-08-01 | US |
| (72) |
MAECKER, Heather, US
IRVING, Bryan, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS |
| METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS |